Clinical Trial Update: Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma [NA]

View source ↗

Summary

A clinical trial update describing hypofractionated stereotactic linear accelerator radiotherapy for uveal melanoma; the current trial status is listed as unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Snippet

Sponsor: Medical University of Vienna | Conditions: Uveal Melanoma | NA | Status: UNKNOWN